The U.S. Securities and Exchange Commission (SEC) is now at trial in an enforcement action against former biopharmaceutical executive Matthew Panuwat, related to so-called "shadow trading" activities.

The Supreme Court is deciding cases that involve critical decisions affecting our everyday lives while using a procedure that provides little to no transparency to the public. Ahead of the 2022 ...

Forbes contributors publish independent expert analyses and insights. Ollie Barder covers Japanese pop-culture and gaming from Tokyo. Naturally, the first thing I wanted to know was what made ...